Literature DB >> 20406161

Restless leg syndrome associated with olanzapine: a case series.

Shilpa Aggarwal1, Seetald Dodd, Michael Berk.   

Abstract

Restless leg syndrome (RLS) is a common disorder associated with significant distress. We report three cases of drug induced RLS caused by olanzapine. In each case, RLS commenced after initiation of treatment with olanzapine and resolved after ceasing olanzapine. All three patients were subsequently treated with other atypical antipsychotics, risperidone, quetiapine or aripiprazole, without re-emergence of RLS. RLS is associated with central dopaminergic dysfunction. Dopamine agonists and L-dopa reduce the symptoms of RLS, and some agents that block the dopaminergic system aggravate RLS. Greater awareness of potential causes of RLS, and its differentiation from akathisia and illness related agitation might help in reducing the distress associated with it and improving patient compliance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20406161     DOI: 10.2174/157488610790936187

Source DB:  PubMed          Journal:  Curr Drug Saf        ISSN: 1574-8863


  9 in total

1.  Medications associated with restless legs syndrome: a case-control study in the US Renal Data System (USRDS).

Authors:  Donald L Bliwise; Rebecca H Zhang; Nancy G Kutner
Journal:  Sleep Med       Date:  2014-06-13       Impact factor: 3.492

2.  Asenapine-induced restless legs syndrome: differentiation from akathisia.

Authors:  W Vaughn McCall; Mary Anne Riley; Chelsea Hodges; Laryssa McCloud; Marjorie Phillips; Peter B Rosenquist
Journal:  J Clin Sleep Med       Date:  2014-12-15       Impact factor: 4.062

Review 3.  Use of α2δ Ligands for Restless Legs Syndrome/Willis Ekbom Disease.

Authors:  Michele A Faulkner
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

4.  Review of the treatment of restless legs syndrome: focus on gabapentin enacarbil.

Authors:  Rachel A Burke; Michele A Faulkner
Journal:  J Cent Nerv Syst Dis       Date:  2012-09-17

5.  Clinical Study of Restless Leg Syndrome Accompanied by Psychological Symptoms Induced by High-Dose Treatment With Madopar.

Authors:  Lei Zhu; Jing Li; Chongyang Ren; Mei Zhang; Min Xue; Chuanqing Yu; Weili Zhang
Journal:  Front Psychiatry       Date:  2019-05-24       Impact factor: 4.157

Review 6.  Why Are Women Prone to Restless Legs Syndrome?

Authors:  Mary V Seeman
Journal:  Int J Environ Res Public Health       Date:  2020-01-06       Impact factor: 3.390

Review 7.  Restless Legs Syndrome and the Use of Antipsychotic Medication: An Updated Literature Review.

Authors:  Wael K Saber; Ahad R Almuallim; Rami Algahtani
Journal:  Cureus       Date:  2022-08-09

8.  Rethinking bedtime resistance in children with autism: is restless legs syndrome to blame?

Authors:  Michelle L Kanney; Jeffrey S Durmer; Lynn Marie Trotti; Roberta Leu
Journal:  J Clin Sleep Med       Date:  2020-12-15       Impact factor: 4.062

9.  Olanzapine-induced restless leg syndrome: a case report and review of literature.

Authors:  Aniruddha Basu; Savita Kundu; Hitesh Khurana
Journal:  Indian J Pharmacol       Date:  2014 Jul-Aug       Impact factor: 1.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.